Novozymes A/S

Common Name

Novozymes

Country

Denmark

Sector

Basic Materials

Industry

Specialty Chemicals

Employees

10,582

Ticker

NSIS B

Exchange

NASDAQ COPENHAGEN A/S

Website

www.novozymes.com

Description

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and in... Show more

Income Statement Balance Sheet

Financial Statements of Novozymes

Below are the financial statements of Novozymes, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of EUR	2024 as of 2024-12-31	2023 as of 2023-12-31
Goodwill	5,605^a	265^a
Other intangible assets	4,419.2^a	343^a
Property, plant and equipment	2,968.3^a	1,653.8^a
Deferred tax assets	275^a	236.4^a
Other financial assets	18.7^a	8.3^a
Investments in associates	24^a	27.5^a
Other receivables	6^a	5.9^a
Non-current assets	13,316.2^a	2,539.9^a
Inventories	720.6^a	486.7^a
Trade receivables	665.6^a	496.7^a
Contract assets	23.6^a	9.4^a
Tax receivables	58.6^a	39.7^a
Other receivables	115.4^a	37.4^a
Other financial assets	4^a	5.4^a
Cash and cash equivalents	280^a	149.7^a
Assets held for sale	11.6^a	44.5^a
Current assets	1,879.4^a	1,269.5^a
Assets	15,195.6^a	3,809.4^a
Common shares	125.6^a	75.4^a
Reserves and retained earnings	11,050.4^a	1,800.2^a
Equity attributable to shareholders of Novozymes A/S	11,176^a	1,875.6^a
Non-controlling interests	0^a	50^a
Total equity	11,176^a	1,925.6^a
Deferred tax liabilities	1,255.9^a	263.6^a
Provisions	39.7^a	15.1^a
Contract liabilities	105.3^a	20.4^a
Borrowings	1,530.4^a	612^a
Non-current liabilities	2,931.3^a	911.1^a
Share purchase liability	0^a	78.4^a
Borrowings	266.4^a	432^a
Trade payables	423.1^a	216.9^a
Contract liabilities	22.8^a	8.7^a
Tax payables	60.9^a	24.6^a
Other liabilities	315.1^a	212.1^a
Current liabilities	1,088.3^a	972.7^a
Liabilities	4,019.6^a	1,883.8^a
Liabilities and equity	15,195.6^a	3,809.4^a

Download Data

Verified Sources Behind Novozymes’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novozymes’s data sources below and access millions more through our Disclosure Search.

a. Novozymes's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Novozymes A/S

Financial Statements of Novozymes

Verified Sources Behind Novozymes’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Givaudan SA

Asian Paints Ltd

Ems Chemie Holding AG

Luxi Chemical Group Co Ltd

Arkema SA

Nitto Denko Corp